PURPOSE: This study aimed to assess the prevalence of anxiety and depression and related factors in pregnant women during the coronavirus disease 2019 (COVID-19) pandemic. DESIGN AND METHODS: This cross-sectional study was conducted on 403 pregnant women using a web-based survey. The hospital anxiety and depression scale was used to measure anxiety and depression. FINDINGS: The prevalence of anxiety and depression was 64.5% and 56.3%, respectively. Working status, physical activity status, discomfort with hospital visits, having information about COVID-19, and being informed by healthcare workers about COVID-19 were factors related to anxiety (p < .05). Education level, physical activity status, discomfort with hospital visits, and having information about COVID-19 were factors related to depression (p < .05). PRACTICE IMPLICATIONS: The aforementioned factors should be considered for reducing anxiety and depressive symptoms during pregnancy.
No takes yet. Share an insight, caveat, or question.
Süt et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: